Avantor, Inc. is a life science tools company that engages in providing mission-critical products and services to the life sciences and advanced technology industries. The company is headquartered in Radnor, Pennsylvania and currently employs 13,500 full-time employees. The company went IPO on 2019-05-17. The Company’s segments include Laboratory Solutions and Bioscience Production. Within its segments, it sells materials and consumables, equipment and instrumentation and services and specialty procurement to customers in the biopharma and healthcare, education and government and advanced technologies and applied materials industries. Materials and consumables include ultra-high purity chemicals and reagents, lab products and supplies, highly specialized formulated silicone materials, customized excipients, and others. Equipment and instrumentation include filtration systems, virus inactivation systems, incubators, analytical instruments, and others. Services and specialty procurement include onsite lab and production, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
Follow-Up Questions
Avantor Inc (AVTR)의 PER은 얼마입니까?
Avantor Inc의 PER은 13.2946입니다
Avantor Inc의 CEO는 누구입니까?
Mr. Emmanuel Ligner은 2025부터 회사에 합류한 Avantor Inc의 President입니다.
AVTR 주식의 가격 성능은 어떻습니까?
AVTR의 현재 가격은 $11.59이며, 전 거래일에 increased 0.09% 하였습니다.
Avantor Inc의 주요 사업 주제나 업종은 무엇입니까?
Avantor Inc은 Life Sciences Tools & Services 업종에 속하며, 해당 부문은 Health Care입니다
Avantor Inc의 시가총액은 얼마입니까?
Avantor Inc의 현재 시가총액은 $7.9B입니다
Avantor Inc는 매수, 매도, 아니면 보유해야 하나요?
월스트리트 분석가들에 따르면, 20명의 분석가가 Avantor Inc에 대한 분석 평가를 실시했으며, 이는 4명의 강력한 매수, 10명의 매수, 15명의 보유, 0명의 매도, 그리고 4명의 강력한 매도를 포함합니다
